nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—HTR6—Raloxifene—osteoporosis	0.0925	0.137	CbGbCtD
Imipramine—SLC22A1—Estropipate—osteoporosis	0.0837	0.124	CbGbCtD
Imipramine—SLC22A3—Estradiol—osteoporosis	0.0676	0.1	CbGbCtD
Imipramine—SLC22A2—Estradiol—osteoporosis	0.04	0.0593	CbGbCtD
Imipramine—SLC22A1—Estradiol—osteoporosis	0.0347	0.0515	CbGbCtD
Imipramine—CYP2B6—Raloxifene—osteoporosis	0.0334	0.0495	CbGbCtD
Imipramine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0322	0.0478	CbGbCtD
Imipramine—CYP1A2—Estropipate—osteoporosis	0.0293	0.0435	CbGbCtD
Imipramine—CYP2B6—Cholecalciferol—osteoporosis	0.0258	0.0382	CbGbCtD
Imipramine—CYP3A7—Estradiol—osteoporosis	0.0218	0.0323	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0218	0.0323	CbGbCtD
Imipramine—ABCB1—Ethinyl Estradiol—osteoporosis	0.0165	0.0245	CbGbCtD
Imipramine—CYP2C19—Cholecalciferol—osteoporosis	0.0164	0.0243	CbGbCtD
Imipramine—CYP3A4—Estropipate—osteoporosis	0.0154	0.0228	CbGbCtD
Imipramine—CYP3A4—Calcitriol—osteoporosis	0.0154	0.0228	CbGbCtD
Imipramine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0139	0.0206	CbGbCtD
Imipramine—CYP2C19—Estradiol—osteoporosis	0.0132	0.0196	CbGbCtD
Imipramine—CYP2D6—Cholecalciferol—osteoporosis	0.0124	0.0184	CbGbCtD
Imipramine—CYP3A4—Ergocalciferol—osteoporosis	0.0123	0.0182	CbGbCtD
Imipramine—CYP1A2—Estradiol—osteoporosis	0.0122	0.018	CbGbCtD
Imipramine—ABCB1—Conjugated Estrogens—osteoporosis	0.0121	0.018	CbGbCtD
Imipramine—ABCB1—Estradiol—osteoporosis	0.0106	0.0158	CbGbCtD
Imipramine—CYP3A4—Raloxifene—osteoporosis	0.0102	0.0152	CbGbCtD
Imipramine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0099	0.0147	CbGbCtD
Imipramine—CYP3A4—Cholecalciferol—osteoporosis	0.00791	0.0117	CbGbCtD
Imipramine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00726	0.0108	CbGbCtD
Imipramine—CYP3A4—Estradiol—osteoporosis	0.00638	0.00946	CbGbCtD
Imipramine—Benazepril—MTHFR—osteoporosis	0.000592	0.551	CrCbGaD
Imipramine—Benazepril—ACE—osteoporosis	0.000483	0.449	CrCbGaD
Imipramine—Urticaria—Calcitriol—osteoporosis	0.000263	0.0011	CcSEcCtD
Imipramine—Hepatitis—Estradiol—osteoporosis	0.000262	0.0011	CcSEcCtD
Imipramine—Palpitations—Zoledronate—osteoporosis	0.000262	0.0011	CcSEcCtD
Imipramine—Body temperature increased—Calcitriol—osteoporosis	0.000261	0.0011	CcSEcCtD
Imipramine—Abdominal pain—Calcitriol—osteoporosis	0.000261	0.0011	CcSEcCtD
Imipramine—Hypoaesthesia—Estradiol—osteoporosis	0.000261	0.00109	CcSEcCtD
Imipramine—Shock—Pamidronate—osteoporosis	0.00026	0.00109	CcSEcCtD
Imipramine—Loss of consciousness—Zoledronate—osteoporosis	0.00026	0.00109	CcSEcCtD
Imipramine—Nervous system disorder—Pamidronate—osteoporosis	0.000259	0.00109	CcSEcCtD
Imipramine—Thrombocytopenia—Pamidronate—osteoporosis	0.000259	0.00109	CcSEcCtD
Imipramine—Urinary tract disorder—Estradiol—osteoporosis	0.000259	0.00108	CcSEcCtD
Imipramine—Vomiting—Etidronic acid—osteoporosis	0.000259	0.00108	CcSEcCtD
Imipramine—Tachycardia—Pamidronate—osteoporosis	0.000258	0.00108	CcSEcCtD
Imipramine—Urethral disorder—Estradiol—osteoporosis	0.000257	0.00108	CcSEcCtD
Imipramine—Rash—Etidronic acid—osteoporosis	0.000257	0.00108	CcSEcCtD
Imipramine—Convulsion—Zoledronate—osteoporosis	0.000257	0.00108	CcSEcCtD
Imipramine—Dermatitis—Etidronic acid—osteoporosis	0.000256	0.00107	CcSEcCtD
Imipramine—Hyperhidrosis—Pamidronate—osteoporosis	0.000256	0.00107	CcSEcCtD
Imipramine—Syncope—Conjugated Estrogens—osteoporosis	0.000256	0.00107	CcSEcCtD
Imipramine—Hypertension—Zoledronate—osteoporosis	0.000256	0.00107	CcSEcCtD
Imipramine—Headache—Etidronic acid—osteoporosis	0.000255	0.00107	CcSEcCtD
Imipramine—Asthenia—Estropipate—osteoporosis	0.000253	0.00106	CcSEcCtD
Imipramine—Anorexia—Pamidronate—osteoporosis	0.000252	0.00106	CcSEcCtD
Imipramine—Palpitations—Conjugated Estrogens—osteoporosis	0.000252	0.00106	CcSEcCtD
Imipramine—Insomnia—Risedronate—osteoporosis	0.000252	0.00105	CcSEcCtD
Imipramine—Anxiety—Zoledronate—osteoporosis	0.000251	0.00105	CcSEcCtD
Imipramine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000251	0.00105	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00025	0.00105	CcSEcCtD
Imipramine—Paraesthesia—Risedronate—osteoporosis	0.00025	0.00105	CcSEcCtD
Imipramine—Pruritus—Estropipate—osteoporosis	0.000249	0.00104	CcSEcCtD
Imipramine—Discomfort—Zoledronate—osteoporosis	0.000249	0.00104	CcSEcCtD
Imipramine—Asthenia—Alendronate—osteoporosis	0.000249	0.00104	CcSEcCtD
Imipramine—Convulsion—Conjugated Estrogens—osteoporosis	0.000247	0.00104	CcSEcCtD
Imipramine—Dry mouth—Zoledronate—osteoporosis	0.000247	0.00103	CcSEcCtD
Imipramine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000246	0.00103	CcSEcCtD
Imipramine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000246	0.00103	CcSEcCtD
Imipramine—Pruritus—Alendronate—osteoporosis	0.000245	0.00103	CcSEcCtD
Imipramine—Dyspepsia—Risedronate—osteoporosis	0.000245	0.00103	CcSEcCtD
Imipramine—Eye disorder—Estradiol—osteoporosis	0.000245	0.00103	CcSEcCtD
Imipramine—Tinnitus—Estradiol—osteoporosis	0.000244	0.00102	CcSEcCtD
Imipramine—Constipation—Ethinyl Estradiol—osteoporosis	0.000244	0.00102	CcSEcCtD
Imipramine—Confusional state—Zoledronate—osteoporosis	0.000244	0.00102	CcSEcCtD
Imipramine—Flushing—Estradiol—osteoporosis	0.000243	0.00102	CcSEcCtD
Imipramine—Cardiac disorder—Estradiol—osteoporosis	0.000243	0.00102	CcSEcCtD
Imipramine—Asthenia—Ibandronate—osteoporosis	0.000242	0.00102	CcSEcCtD
Imipramine—Anxiety—Conjugated Estrogens—osteoporosis	0.000242	0.00101	CcSEcCtD
Imipramine—Nausea—Etidronic acid—osteoporosis	0.000242	0.00101	CcSEcCtD
Imipramine—Anaphylactic shock—Zoledronate—osteoporosis	0.000242	0.00101	CcSEcCtD
Imipramine—Oedema—Zoledronate—osteoporosis	0.000242	0.00101	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000241	0.00101	CcSEcCtD
Imipramine—Diarrhoea—Estropipate—osteoporosis	0.000241	0.00101	CcSEcCtD
Imipramine—Gastrointestinal disorder—Risedronate—osteoporosis	0.00024	0.00101	CcSEcCtD
Imipramine—Infection—Zoledronate—osteoporosis	0.00024	0.00101	CcSEcCtD
Imipramine—Fatigue—Risedronate—osteoporosis	0.00024	0.00101	CcSEcCtD
Imipramine—Insomnia—Pamidronate—osteoporosis	0.000239	0.001	CcSEcCtD
Imipramine—Pruritus—Ibandronate—osteoporosis	0.000239	0.001	CcSEcCtD
Imipramine—Constipation—Risedronate—osteoporosis	0.000238	0.000997	CcSEcCtD
Imipramine—Angiopathy—Estradiol—osteoporosis	0.000238	0.000997	CcSEcCtD
Imipramine—Shock—Zoledronate—osteoporosis	0.000238	0.000996	CcSEcCtD
Imipramine—Paraesthesia—Pamidronate—osteoporosis	0.000238	0.000996	CcSEcCtD
Imipramine—Diarrhoea—Alendronate—osteoporosis	0.000237	0.000995	CcSEcCtD
Imipramine—Asthenia—Calcitriol—osteoporosis	0.000237	0.000994	CcSEcCtD
Imipramine—Nervous system disorder—Zoledronate—osteoporosis	0.000237	0.000993	CcSEcCtD
Imipramine—Immune system disorder—Estradiol—osteoporosis	0.000237	0.000992	CcSEcCtD
Imipramine—Thrombocytopenia—Zoledronate—osteoporosis	0.000237	0.000992	CcSEcCtD
Imipramine—Mediastinal disorder—Estradiol—osteoporosis	0.000236	0.00099	CcSEcCtD
Imipramine—Tachycardia—Zoledronate—osteoporosis	0.000236	0.000988	CcSEcCtD
Imipramine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000235	0.000986	CcSEcCtD
Imipramine—Somnolence—Pamidronate—osteoporosis	0.000235	0.000986	CcSEcCtD
Imipramine—Skin disorder—Zoledronate—osteoporosis	0.000235	0.000984	CcSEcCtD
Imipramine—Pruritus—Calcitriol—osteoporosis	0.000234	0.00098	CcSEcCtD
Imipramine—Hyperhidrosis—Zoledronate—osteoporosis	0.000234	0.000979	CcSEcCtD
Imipramine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000233	0.000978	CcSEcCtD
Imipramine—Diarrhoea—Raloxifene—osteoporosis	0.000233	0.000978	CcSEcCtD
Imipramine—Dyspepsia—Pamidronate—osteoporosis	0.000233	0.000976	CcSEcCtD
Imipramine—Dizziness—Estropipate—osteoporosis	0.000233	0.000976	CcSEcCtD
Imipramine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000233	0.000975	CcSEcCtD
Imipramine—Oedema—Conjugated Estrogens—osteoporosis	0.000233	0.000975	CcSEcCtD
Imipramine—Alopecia—Estradiol—osteoporosis	0.000232	0.000971	CcSEcCtD
Imipramine—Infection—Conjugated Estrogens—osteoporosis	0.000231	0.000969	CcSEcCtD
Imipramine—Diarrhoea—Ibandronate—osteoporosis	0.000231	0.000968	CcSEcCtD
Imipramine—Anorexia—Zoledronate—osteoporosis	0.00023	0.000965	CcSEcCtD
Imipramine—Decreased appetite—Pamidronate—osteoporosis	0.00023	0.000964	CcSEcCtD
Imipramine—Mental disorder—Estradiol—osteoporosis	0.00023	0.000962	CcSEcCtD
Imipramine—Dizziness—Alendronate—osteoporosis	0.000229	0.000961	CcSEcCtD
Imipramine—Shock—Conjugated Estrogens—osteoporosis	0.000229	0.000959	CcSEcCtD
Imipramine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000228	0.000957	CcSEcCtD
Imipramine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000228	0.000956	CcSEcCtD
Imipramine—Malnutrition—Estradiol—osteoporosis	0.000228	0.000956	CcSEcCtD
Imipramine—Fatigue—Pamidronate—osteoporosis	0.000228	0.000956	CcSEcCtD
Imipramine—Gastrointestinal pain—Risedronate—osteoporosis	0.000228	0.000954	CcSEcCtD
Imipramine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000227	0.000952	CcSEcCtD
Imipramine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000227	0.00095	CcSEcCtD
Imipramine—Constipation—Pamidronate—osteoporosis	0.000226	0.000948	CcSEcCtD
Imipramine—Diarrhoea—Calcitriol—osteoporosis	0.000226	0.000948	CcSEcCtD
Imipramine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000226	0.000947	CcSEcCtD
Imipramine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000226	0.000946	CcSEcCtD
Imipramine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000226	0.000946	CcSEcCtD
Imipramine—Dizziness—Raloxifene—osteoporosis	0.000226	0.000945	CcSEcCtD
Imipramine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000225	0.000943	CcSEcCtD
Imipramine—Tension—Estradiol—osteoporosis	0.000224	0.000938	CcSEcCtD
Imipramine—Vomiting—Estropipate—osteoporosis	0.000224	0.000938	CcSEcCtD
Imipramine—Dysgeusia—Estradiol—osteoporosis	0.000223	0.000936	CcSEcCtD
Imipramine—Dizziness—Ibandronate—osteoporosis	0.000223	0.000936	CcSEcCtD
Imipramine—Rash—Estropipate—osteoporosis	0.000222	0.000931	CcSEcCtD
Imipramine—Dermatitis—Estropipate—osteoporosis	0.000222	0.00093	CcSEcCtD
Imipramine—Anorexia—Conjugated Estrogens—osteoporosis	0.000222	0.00093	CcSEcCtD
Imipramine—Nervousness—Estradiol—osteoporosis	0.000222	0.000929	CcSEcCtD
Imipramine—Urticaria—Risedronate—osteoporosis	0.000221	0.000927	CcSEcCtD
Imipramine—Headache—Estropipate—osteoporosis	0.000221	0.000925	CcSEcCtD
Imipramine—Vomiting—Alendronate—osteoporosis	0.000221	0.000924	CcSEcCtD
Imipramine—Abdominal pain—Risedronate—osteoporosis	0.00022	0.000922	CcSEcCtD
Imipramine—Body temperature increased—Risedronate—osteoporosis	0.00022	0.000922	CcSEcCtD
Imipramine—Rash—Alendronate—osteoporosis	0.000219	0.000917	CcSEcCtD
Imipramine—Insomnia—Zoledronate—osteoporosis	0.000219	0.000916	CcSEcCtD
Imipramine—Dermatitis—Alendronate—osteoporosis	0.000218	0.000916	CcSEcCtD
Imipramine—Feeling abnormal—Pamidronate—osteoporosis	0.000218	0.000914	CcSEcCtD
Imipramine—Headache—Alendronate—osteoporosis	0.000217	0.000911	CcSEcCtD
Imipramine—Paraesthesia—Zoledronate—osteoporosis	0.000217	0.000909	CcSEcCtD
Imipramine—Vomiting—Raloxifene—osteoporosis	0.000217	0.000909	CcSEcCtD
Imipramine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000216	0.000907	CcSEcCtD
Imipramine—Rash—Raloxifene—osteoporosis	0.000215	0.000901	CcSEcCtD
Imipramine—Dermatitis—Raloxifene—osteoporosis	0.000215	0.000901	CcSEcCtD
Imipramine—Somnolence—Zoledronate—osteoporosis	0.000215	0.0009	CcSEcCtD
Imipramine—Vomiting—Ibandronate—osteoporosis	0.000215	0.0009	CcSEcCtD
Imipramine—Tremor—Estradiol—osteoporosis	0.000214	0.000896	CcSEcCtD
Imipramine—Headache—Raloxifene—osteoporosis	0.000214	0.000896	CcSEcCtD
Imipramine—Rash—Ibandronate—osteoporosis	0.000213	0.000892	CcSEcCtD
Imipramine—Dermatitis—Ibandronate—osteoporosis	0.000213	0.000891	CcSEcCtD
Imipramine—Dyspepsia—Zoledronate—osteoporosis	0.000213	0.000891	CcSEcCtD
Imipramine—Ill-defined disorder—Estradiol—osteoporosis	0.000212	0.000887	CcSEcCtD
Imipramine—Headache—Ibandronate—osteoporosis	0.000212	0.000887	CcSEcCtD
Imipramine—Insomnia—Conjugated Estrogens—osteoporosis	0.00021	0.000882	CcSEcCtD
Imipramine—Vomiting—Calcitriol—osteoporosis	0.00021	0.000881	CcSEcCtD
Imipramine—Decreased appetite—Zoledronate—osteoporosis	0.00021	0.00088	CcSEcCtD
Imipramine—Agitation—Estradiol—osteoporosis	0.00021	0.000879	CcSEcCtD
Imipramine—Nausea—Estropipate—osteoporosis	0.000209	0.000877	CcSEcCtD
Imipramine—Body temperature increased—Pamidronate—osteoporosis	0.000209	0.000876	CcSEcCtD
Imipramine—Abdominal pain—Pamidronate—osteoporosis	0.000209	0.000876	CcSEcCtD
Imipramine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000209	0.000876	CcSEcCtD
Imipramine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000209	0.000874	CcSEcCtD
Imipramine—Rash—Calcitriol—osteoporosis	0.000208	0.000873	CcSEcCtD
Imipramine—Fatigue—Zoledronate—osteoporosis	0.000208	0.000873	CcSEcCtD
Imipramine—Dermatitis—Calcitriol—osteoporosis	0.000208	0.000873	CcSEcCtD
Imipramine—Headache—Calcitriol—osteoporosis	0.000207	0.000868	CcSEcCtD
Imipramine—Somnolence—Conjugated Estrogens—osteoporosis	0.000207	0.000867	CcSEcCtD
Imipramine—Constipation—Zoledronate—osteoporosis	0.000207	0.000866	CcSEcCtD
Imipramine—Nausea—Alendronate—osteoporosis	0.000206	0.000863	CcSEcCtD
Imipramine—Malaise—Estradiol—osteoporosis	0.000206	0.000862	CcSEcCtD
Imipramine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000205	0.000858	CcSEcCtD
Imipramine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000205	0.000858	CcSEcCtD
Imipramine—Syncope—Estradiol—osteoporosis	0.000205	0.000858	CcSEcCtD
Imipramine—Nausea—Raloxifene—osteoporosis	0.000203	0.000849	CcSEcCtD
Imipramine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000202	0.000848	CcSEcCtD
Imipramine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000202	0.000846	CcSEcCtD
Imipramine—Palpitations—Estradiol—osteoporosis	0.000202	0.000845	CcSEcCtD
Imipramine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000201	0.000842	CcSEcCtD
Imipramine—Fatigue—Conjugated Estrogens—osteoporosis	0.000201	0.000841	CcSEcCtD
Imipramine—Nausea—Ibandronate—osteoporosis	0.000201	0.000841	CcSEcCtD
Imipramine—Loss of consciousness—Estradiol—osteoporosis	0.000201	0.00084	CcSEcCtD
Imipramine—Asthenia—Risedronate—osteoporosis	0.0002	0.000837	CcSEcCtD
Imipramine—Feeling abnormal—Zoledronate—osteoporosis	0.000199	0.000835	CcSEcCtD
Imipramine—Constipation—Conjugated Estrogens—osteoporosis	0.000199	0.000834	CcSEcCtD
Imipramine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000198	0.000828	CcSEcCtD
Imipramine—Hypertension—Estradiol—osteoporosis	0.000197	0.000826	CcSEcCtD
Imipramine—Pruritus—Risedronate—osteoporosis	0.000197	0.000825	CcSEcCtD
Imipramine—Nausea—Calcitriol—osteoporosis	0.000196	0.000823	CcSEcCtD
Imipramine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000195	0.000818	CcSEcCtD
Imipramine—Anxiety—Estradiol—osteoporosis	0.000194	0.000811	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000193	0.000809	CcSEcCtD
Imipramine—Urticaria—Zoledronate—osteoporosis	0.000192	0.000805	CcSEcCtD
Imipramine—Discomfort—Estradiol—osteoporosis	0.000192	0.000804	CcSEcCtD
Imipramine—Abdominal pain—Zoledronate—osteoporosis	0.000191	0.000801	CcSEcCtD
Imipramine—Body temperature increased—Zoledronate—osteoporosis	0.000191	0.000801	CcSEcCtD
Imipramine—Diarrhoea—Risedronate—osteoporosis	0.00019	0.000798	CcSEcCtD
Imipramine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00019	0.000797	CcSEcCtD
Imipramine—Dry mouth—Estradiol—osteoporosis	0.00019	0.000796	CcSEcCtD
Imipramine—Asthenia—Pamidronate—osteoporosis	0.00019	0.000795	CcSEcCtD
Imipramine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000189	0.000791	CcSEcCtD
Imipramine—Confusional state—Estradiol—osteoporosis	0.000188	0.000787	CcSEcCtD
Imipramine—Pruritus—Pamidronate—osteoporosis	0.000187	0.000784	CcSEcCtD
Imipramine—Oedema—Estradiol—osteoporosis	0.000186	0.00078	CcSEcCtD
Imipramine—Anaphylactic shock—Estradiol—osteoporosis	0.000186	0.00078	CcSEcCtD
Imipramine—Infection—Estradiol—osteoporosis	0.000185	0.000775	CcSEcCtD
Imipramine—Urticaria—Conjugated Estrogens—osteoporosis	0.000185	0.000775	CcSEcCtD
Imipramine—Dizziness—Risedronate—osteoporosis	0.000184	0.000771	CcSEcCtD
Imipramine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000184	0.000771	CcSEcCtD
Imipramine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000184	0.000771	CcSEcCtD
Imipramine—Shock—Estradiol—osteoporosis	0.000183	0.000768	CcSEcCtD
Imipramine—Nervous system disorder—Estradiol—osteoporosis	0.000183	0.000765	CcSEcCtD
Imipramine—Tachycardia—Estradiol—osteoporosis	0.000182	0.000762	CcSEcCtD
Imipramine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000181	0.000761	CcSEcCtD
Imipramine—Diarrhoea—Pamidronate—osteoporosis	0.000181	0.000759	CcSEcCtD
Imipramine—Skin disorder—Estradiol—osteoporosis	0.000181	0.000758	CcSEcCtD
Imipramine—Hyperhidrosis—Estradiol—osteoporosis	0.00018	0.000754	CcSEcCtD
Imipramine—Rash—Ethinyl Estradiol—osteoporosis	0.00018	0.000754	CcSEcCtD
Imipramine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00018	0.000754	CcSEcCtD
Imipramine—Headache—Ethinyl Estradiol—osteoporosis	0.000179	0.000749	CcSEcCtD
Imipramine—Vomiting—Risedronate—osteoporosis	0.000177	0.000742	CcSEcCtD
Imipramine—Rash—Risedronate—osteoporosis	0.000175	0.000735	CcSEcCtD
Imipramine—Dermatitis—Risedronate—osteoporosis	0.000175	0.000735	CcSEcCtD
Imipramine—Dizziness—Pamidronate—osteoporosis	0.000175	0.000733	CcSEcCtD
Imipramine—Headache—Risedronate—osteoporosis	0.000174	0.000731	CcSEcCtD
Imipramine—Asthenia—Zoledronate—osteoporosis	0.000173	0.000727	CcSEcCtD
Imipramine—Pruritus—Zoledronate—osteoporosis	0.000171	0.000717	CcSEcCtD
Imipramine—Nausea—Ethinyl Estradiol—osteoporosis	0.00017	0.000711	CcSEcCtD
Imipramine—Insomnia—Estradiol—osteoporosis	0.000168	0.000706	CcSEcCtD
Imipramine—Vomiting—Pamidronate—osteoporosis	0.000168	0.000705	CcSEcCtD
Imipramine—Paraesthesia—Estradiol—osteoporosis	0.000167	0.000701	CcSEcCtD
Imipramine—Asthenia—Conjugated Estrogens—osteoporosis	0.000167	0.0007	CcSEcCtD
Imipramine—Rash—Pamidronate—osteoporosis	0.000167	0.000699	CcSEcCtD
Imipramine—Dermatitis—Pamidronate—osteoporosis	0.000167	0.000698	CcSEcCtD
Imipramine—Headache—Pamidronate—osteoporosis	0.000166	0.000695	CcSEcCtD
Imipramine—Somnolence—Estradiol—osteoporosis	0.000166	0.000694	CcSEcCtD
Imipramine—Diarrhoea—Zoledronate—osteoporosis	0.000165	0.000693	CcSEcCtD
Imipramine—Nausea—Risedronate—osteoporosis	0.000165	0.000693	CcSEcCtD
Imipramine—Pruritus—Conjugated Estrogens—osteoporosis	0.000165	0.00069	CcSEcCtD
Imipramine—Dyspepsia—Estradiol—osteoporosis	0.000164	0.000687	CcSEcCtD
Imipramine—Decreased appetite—Estradiol—osteoporosis	0.000162	0.000678	CcSEcCtD
Imipramine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000161	0.000674	CcSEcCtD
Imipramine—Fatigue—Estradiol—osteoporosis	0.000161	0.000673	CcSEcCtD
Imipramine—Dizziness—Zoledronate—osteoporosis	0.00016	0.00067	CcSEcCtD
Imipramine—Constipation—Estradiol—osteoporosis	0.000159	0.000667	CcSEcCtD
Imipramine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000159	0.000667	CcSEcCtD
Imipramine—Nausea—Pamidronate—osteoporosis	0.000157	0.000659	CcSEcCtD
Imipramine—Dizziness—Conjugated Estrogens—osteoporosis	0.000154	0.000645	CcSEcCtD
Imipramine—Vomiting—Zoledronate—osteoporosis	0.000154	0.000644	CcSEcCtD
Imipramine—Feeling abnormal—Estradiol—osteoporosis	0.000153	0.000643	CcSEcCtD
Imipramine—Rash—Zoledronate—osteoporosis	0.000152	0.000639	CcSEcCtD
Imipramine—Gastrointestinal pain—Estradiol—osteoporosis	0.000152	0.000638	CcSEcCtD
Imipramine—Dermatitis—Zoledronate—osteoporosis	0.000152	0.000638	CcSEcCtD
Imipramine—Headache—Zoledronate—osteoporosis	0.000151	0.000634	CcSEcCtD
Imipramine—Vomiting—Conjugated Estrogens—osteoporosis	0.000148	0.00062	CcSEcCtD
Imipramine—Urticaria—Estradiol—osteoporosis	0.000148	0.00062	CcSEcCtD
Imipramine—Body temperature increased—Estradiol—osteoporosis	0.000147	0.000617	CcSEcCtD
Imipramine—Abdominal pain—Estradiol—osteoporosis	0.000147	0.000617	CcSEcCtD
Imipramine—Rash—Conjugated Estrogens—osteoporosis	0.000147	0.000615	CcSEcCtD
Imipramine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000147	0.000614	CcSEcCtD
Imipramine—Headache—Conjugated Estrogens—osteoporosis	0.000146	0.000611	CcSEcCtD
Imipramine—Nausea—Zoledronate—osteoporosis	0.000144	0.000602	CcSEcCtD
Imipramine—Nausea—Conjugated Estrogens—osteoporosis	0.000138	0.000579	CcSEcCtD
Imipramine—Asthenia—Estradiol—osteoporosis	0.000134	0.00056	CcSEcCtD
Imipramine—Pruritus—Estradiol—osteoporosis	0.000132	0.000552	CcSEcCtD
Imipramine—Diarrhoea—Estradiol—osteoporosis	0.000127	0.000534	CcSEcCtD
Imipramine—Dizziness—Estradiol—osteoporosis	0.000123	0.000516	CcSEcCtD
Imipramine—Vomiting—Estradiol—osteoporosis	0.000118	0.000496	CcSEcCtD
Imipramine—Rash—Estradiol—osteoporosis	0.000117	0.000492	CcSEcCtD
Imipramine—Dermatitis—Estradiol—osteoporosis	0.000117	0.000492	CcSEcCtD
Imipramine—Headache—Estradiol—osteoporosis	0.000117	0.000489	CcSEcCtD
Imipramine—Nausea—Estradiol—osteoporosis	0.000111	0.000464	CcSEcCtD
Imipramine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	9.87e-06	0.000115	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6R—osteoporosis	9.83e-06	0.000115	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6R—osteoporosis	9.81e-06	0.000114	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—LEP—osteoporosis	9.79e-06	0.000114	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6R—osteoporosis	9.78e-06	0.000114	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—ESR1—osteoporosis	9.76e-06	0.000114	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6R—osteoporosis	9.75e-06	0.000114	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IRS1—osteoporosis	9.67e-06	0.000113	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IRS1—osteoporosis	9.66e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	9.66e-06	0.000112	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—P4HB—osteoporosis	9.63e-06	0.000112	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	9.63e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—ADCY5—osteoporosis	9.6e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—GPX1—osteoporosis	9.57e-06	0.000111	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MTHFR—osteoporosis	9.56e-06	0.000111	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ENO1—osteoporosis	9.55e-06	0.000111	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GAPDH—osteoporosis	9.46e-06	0.00011	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PSMA5—osteoporosis	9.41e-06	0.00011	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PSMA2—osteoporosis	9.41e-06	0.00011	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	9.41e-06	0.00011	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ADCY5—osteoporosis	9.37e-06	0.000109	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—ESR1—osteoporosis	9.35e-06	0.000109	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ENO1—osteoporosis	9.33e-06	0.000109	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ADCY5—osteoporosis	9.32e-06	0.000109	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—POMC—osteoporosis	9.31e-06	0.000108	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—POMC—osteoporosis	9.3e-06	0.000108	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—IDH2—osteoporosis	9.3e-06	0.000108	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—RAP1A—osteoporosis	9.21e-06	0.000107	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—LEP—osteoporosis	9.21e-06	0.000107	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PSMA5—osteoporosis	9.19e-06	0.000107	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PSMA2—osteoporosis	9.19e-06	0.000107	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IRS1—osteoporosis	9.12e-06	0.000106	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6R—osteoporosis	9.08e-06	0.000106	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6R—osteoporosis	9.07e-06	0.000106	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SPP1—osteoporosis	9.07e-06	0.000106	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SPP1—osteoporosis	9.02e-06	0.000105	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IGF1—osteoporosis	8.96e-06	0.000104	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IGF1—osteoporosis	8.95e-06	0.000104	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	8.92e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MTHFR—osteoporosis	8.83e-06	0.000103	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	8.79e-06	0.000102	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ENO1—osteoporosis	8.79e-06	0.000102	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—POMC—osteoporosis	8.78e-06	0.000102	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.74e-06	0.000102	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IRS1—osteoporosis	8.74e-06	0.000102	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PSMA2—osteoporosis	8.66e-06	0.000101	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PSMA5—osteoporosis	8.66e-06	0.000101	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	8.63e-06	0.000101	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6R—osteoporosis	8.57e-06	9.98e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ACP5—osteoporosis	8.51e-06	9.91e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IGF1—osteoporosis	8.45e-06	9.84e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—POMC—osteoporosis	8.41e-06	9.8e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—ADCY5—osteoporosis	8.26e-06	9.62e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GPX1—osteoporosis	8.23e-06	9.59e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ADCY5—osteoporosis	8.23e-06	9.59e-05	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—POMC—osteoporosis	8.21e-06	9.57e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	8.21e-06	9.57e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6R—osteoporosis	8.21e-06	9.56e-05	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—POMC—osteoporosis	8.2e-06	9.55e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IRS2—osteoporosis	8.2e-06	9.55e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IRS2—osteoporosis	8.16e-06	9.5e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ADCY5—osteoporosis	8.1e-06	9.43e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IGF1—osteoporosis	8.09e-06	9.43e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—ADCY5—osteoporosis	8.09e-06	9.42e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ADCY5—osteoporosis	8.08e-06	9.41e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GPX1—osteoporosis	8.06e-06	9.39e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ADCY5—osteoporosis	8.05e-06	9.38e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.03e-06	9.36e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ADCY5—osteoporosis	8.03e-06	9.35e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—LEP—osteoporosis	8.02e-06	9.35e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—LEP—osteoporosis	7.98e-06	9.3e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SPP1—osteoporosis	7.96e-06	9.27e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	7.95e-06	9.26e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	7.93e-06	9.24e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—POMC—osteoporosis	7.91e-06	9.21e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—TPI1—osteoporosis	7.91e-06	9.21e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SPP1—osteoporosis	7.83e-06	9.13e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SPP1—osteoporosis	7.82e-06	9.11e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	7.81e-06	9.1e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SPP1—osteoporosis	7.79e-06	9.08e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SPP1—osteoporosis	7.77e-06	9.05e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	7.72e-06	8.99e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SPP1—osteoporosis	7.69e-06	8.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	7.67e-06	8.94e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ESR1—osteoporosis	7.66e-06	8.93e-05	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—POMC—osteoporosis	7.64e-06	8.91e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—LEP—osteoporosis	7.64e-06	8.9e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CYP19A1—osteoporosis	7.64e-06	8.9e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ESR1—osteoporosis	7.62e-06	8.88e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	7.61e-06	8.86e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MTHFR—osteoporosis	7.6e-06	8.85e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CYP19A1—osteoporosis	7.45e-06	8.69e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ENO1—osteoporosis	7.44e-06	8.67e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MTHFR—osteoporosis	7.44e-06	8.67e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—P4HB—osteoporosis	7.43e-06	8.66e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PSMA5—osteoporosis	7.34e-06	8.55e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PSMA2—osteoporosis	7.34e-06	8.55e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GAPDH—osteoporosis	7.3e-06	8.5e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	7.3e-06	8.5e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IRS2—osteoporosis	7.2e-06	8.39e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IRS1—osteoporosis	7.16e-06	8.34e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IRS1—osteoporosis	7.12e-06	8.3e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—RAP1A—osteoporosis	7.11e-06	8.28e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IRS2—osteoporosis	7.08e-06	8.25e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IRS2—osteoporosis	7.07e-06	8.23e-05	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—POMC—osteoporosis	7.06e-06	8.23e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IRS2—osteoporosis	7.05e-06	8.21e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—LEP—osteoporosis	7.05e-06	8.21e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CYP19A1—osteoporosis	7.03e-06	8.18e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IRS2—osteoporosis	7.02e-06	8.18e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IRS2—osteoporosis	6.95e-06	8.1e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	6.94e-06	8.08e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—LEP—osteoporosis	6.93e-06	8.08e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—LEP—osteoporosis	6.92e-06	8.06e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—LEP—osteoporosis	6.89e-06	8.03e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—POMC—osteoporosis	6.89e-06	8.03e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—LEP—osteoporosis	6.87e-06	8.01e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—POMC—osteoporosis	6.86e-06	7.99e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—osteoporosis	6.85e-06	7.98e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—osteoporosis	6.84e-06	7.97e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	6.82e-06	7.94e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—LEP—osteoporosis	6.81e-06	7.93e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—LEP—osteoporosis	6.79e-06	7.91e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ESR1—osteoporosis	6.73e-06	7.84e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6R—osteoporosis	6.72e-06	7.83e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6R—osteoporosis	6.69e-06	7.79e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IGF1—osteoporosis	6.63e-06	7.72e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ESR1—osteoporosis	6.62e-06	7.71e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ESR1—osteoporosis	6.6e-06	7.69e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IGF1—osteoporosis	6.6e-06	7.68e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ESR1—osteoporosis	6.58e-06	7.67e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—POMC—osteoporosis	6.56e-06	7.65e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ESR1—osteoporosis	6.56e-06	7.64e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ESR1—osteoporosis	6.5e-06	7.57e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	6.48e-06	7.55e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—osteoporosis	6.46e-06	7.53e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	6.4e-06	7.46e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	6.31e-06	7.36e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IRS1—osteoporosis	6.28e-06	7.32e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—ADCY5—osteoporosis	6.24e-06	7.27e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GPX1—osteoporosis	6.22e-06	7.25e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—osteoporosis	6.19e-06	7.21e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IRS1—osteoporosis	6.18e-06	7.2e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IRS1—osteoporosis	6.17e-06	7.19e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IRS1—osteoporosis	6.15e-06	7.17e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IRS1—osteoporosis	6.13e-06	7.14e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—ADCY5—osteoporosis	6.09e-06	7.1e-05	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—POMC—osteoporosis	6.07e-06	7.08e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IRS1—osteoporosis	6.07e-06	7.07e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GPX1—osteoporosis	6.07e-06	7.07e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	6.06e-06	7.05e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—POMC—osteoporosis	6.05e-06	7.05e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—POMC—osteoporosis	5.95e-06	6.94e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CYP19A1—osteoporosis	5.95e-06	6.93e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—POMC—osteoporosis	5.95e-06	6.93e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—POMC—osteoporosis	5.94e-06	6.92e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—POMC—osteoporosis	5.92e-06	6.9e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—POMC—osteoporosis	5.9e-06	6.88e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6R—osteoporosis	5.9e-06	6.88e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—POMC—osteoporosis	5.85e-06	6.81e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—POMC—osteoporosis	5.83e-06	6.79e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IGF1—osteoporosis	5.82e-06	6.78e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	5.82e-06	6.78e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6R—osteoporosis	5.81e-06	6.77e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6R—osteoporosis	5.8e-06	6.75e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6R—osteoporosis	5.78e-06	6.73e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6R—osteoporosis	5.76e-06	6.71e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ENO1—osteoporosis	5.75e-06	6.69e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—ADCY5—osteoporosis	5.74e-06	6.69e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MTHFR—osteoporosis	5.74e-06	6.69e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IGF1—osteoporosis	5.73e-06	6.67e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GPX1—osteoporosis	5.72e-06	6.66e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IGF1—osteoporosis	5.72e-06	6.66e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6R—osteoporosis	5.7e-06	6.64e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IGF1—osteoporosis	5.7e-06	6.64e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	5.69e-06	6.63e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IGF1—osteoporosis	5.68e-06	6.62e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.66e-06	6.6e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.66e-06	6.6e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IGF1—osteoporosis	5.62e-06	6.55e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	5.61e-06	6.53e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MTHFR—osteoporosis	5.6e-06	6.53e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MYC—osteoporosis	5.38e-06	6.27e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MYC—osteoporosis	5.38e-06	6.26e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TGFB1—osteoporosis	5.37e-06	6.26e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TGFB1—osteoporosis	5.36e-06	6.25e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MTHFR—osteoporosis	5.28e-06	6.15e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MYC—osteoporosis	5.08e-06	5.92e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—osteoporosis	5.07e-06	5.91e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TGFB1—osteoporosis	5.07e-06	5.9e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—osteoporosis	5.04e-06	5.88e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MYC—osteoporosis	4.86e-06	5.67e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—ADCY5—osteoporosis	4.86e-06	5.67e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TGFB1—osteoporosis	4.85e-06	5.65e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GPX1—osteoporosis	4.85e-06	5.65e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	4.83e-06	5.63e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.59e-06	5.35e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—POMC—osteoporosis	4.59e-06	5.35e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MYC—osteoporosis	4.57e-06	5.33e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	4.56e-06	5.31e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—POMC—osteoporosis	4.48e-06	5.22e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—osteoporosis	4.47e-06	5.21e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—osteoporosis	4.45e-06	5.19e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—osteoporosis	4.38e-06	5.1e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—osteoporosis	4.37e-06	5.09e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—osteoporosis	4.36e-06	5.08e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—osteoporosis	4.34e-06	5.06e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—osteoporosis	4.3e-06	5.01e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	4.29e-06	5e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—POMC—osteoporosis	4.22e-06	4.92e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—osteoporosis	4.05e-06	4.71e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—osteoporosis	4.04e-06	4.71e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MYC—osteoporosis	3.98e-06	4.64e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TGFB1—osteoporosis	3.97e-06	4.63e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MYC—osteoporosis	3.96e-06	4.62e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TGFB1—osteoporosis	3.95e-06	4.61e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—osteoporosis	3.82e-06	4.45e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MYC—osteoporosis	3.79e-06	4.42e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	3.79e-06	4.41e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.75e-06	4.37e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GPX1—osteoporosis	3.74e-06	4.36e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—osteoporosis	3.66e-06	4.26e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—POMC—osteoporosis	3.58e-06	4.17e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MYC—osteoporosis	3.5e-06	4.08e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TGFB1—osteoporosis	3.49e-06	4.07e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.45e-06	4.02e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MYC—osteoporosis	3.44e-06	4.01e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—osteoporosis	3.44e-06	4e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MYC—osteoporosis	3.43e-06	4e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TGFB1—osteoporosis	3.43e-06	4e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TGFB1—osteoporosis	3.43e-06	3.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MYC—osteoporosis	3.42e-06	3.99e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TGFB1—osteoporosis	3.42e-06	3.98e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MYC—osteoporosis	3.41e-06	3.98e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TGFB1—osteoporosis	3.4e-06	3.97e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MYC—osteoporosis	3.38e-06	3.94e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	3.37e-06	3.93e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.37e-06	3.93e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.36e-06	3.92e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—osteoporosis	3e-06	3.49e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—osteoporosis	2.98e-06	3.47e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.85e-06	3.32e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—POMC—osteoporosis	2.76e-06	3.22e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—osteoporosis	2.63e-06	3.06e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—osteoporosis	2.59e-06	3.01e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—osteoporosis	2.58e-06	3.01e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—osteoporosis	2.57e-06	3e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—osteoporosis	2.57e-06	2.99e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—osteoporosis	2.54e-06	2.96e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.53e-06	2.95e-05	CbGpPWpGaD
